Figure 3. Tumor-free survival analysis of CRC patients stratified by rs1047781.
With rs1047781 (chr-19 FUT2), the disease-free time of CRC patients grouped by allelic genotypes (AA, AT and TT) was not significantly different (p = 0.066).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.